DNA Oestrogen includes 11 genes involved in oestrogen biosynthesis, oestrogen metabolism, and phase I and phase II detoxification, providing information to guide personalised diet, lifestyle, hormone, and nutra-ceutical recommendations.
Approximately 80% of breast cancer occurs in women with no family history. Oestrogen affects the function of a number of target tissues and research has shown that an increased lifetime exposure to oestrogen is a strong risk factor in the development of breast cancer. DNA Oestrogen tests for gene variants that have been shown to have an impact on how oestrogen is metabolised. Guiding the personalisation of diet, hormone and nutritional supplement recommendations, based on the insight gained from the DNA Oestrogen test, to improve oestrogen metabolism is of benefit to men and women who suffer from numerous oestrogen-dominant conditions and who have higher lifetime exposure to oestrogens, oestrogen metabolites and other carcinogens.
- Men or women with a strong family history of breast, ovarian, colon or prostate cancer
- Women who suffer from oestrogen-dominant conditions such as endometriosis, premenstrual syndrome and uterine fibroid tumours
- Women considering oral contraceptives, hormone replacement therapy or bio-identical hormone supplementation
- Women who are considering in vitro fertilisation or who have been diagnosed with oestrogen receptor-positive breast cancer
The DNA Oestrogen Test Report provides:
- The level of impact of any genetic variants identified
- An explanation of their impact on oestrogen metabolism
- Appropriate nutritional and lifestyle recommendations to support healthy oestrogen metabolism